NEW YORK — Pfizer's surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors' concerns over the pharmaceutical ...

Pfizer reported Friday that a study has found an increased risk of heart problems in patients taking its pain medication Celebrex. The increased heart risk was found in one of two long-term cancer ...

A second cancer study using the drug found no increased heart risk with patients taking 400 mg of Celebrex per day. The standard recommended dose for Celebrex to treat osteoarthritis arthritis — the ...

The full CMI on the next page has more details. If you are worried about taking this medicine, speak to your pharmacist or doctor. 1. Why am I taking CELEBREX RELIEF? CELEBREX RELIEF contains the ...

Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...

The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of ...

Aug. 4, 2005 — The U.S. Food and Drug Administration (FDA) has approved valsartan to reduce cardiovascular mortality in patients with left ventricular dysfunction/failure following a myocardial ...

NEW YORK Pfizer's surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors' concerns over the pharmaceutical ...

Stage 3 colorectal cancer patients with MRD benefit from Celebrex addition to chemotherapy, showing a 40% risk reduction in death for Signatera-positive patients. Celebrex improved disease-free and ...

New York, NY - Celecoxib (Celebrex, Pfizer) is one of the victors of the coxib scare. It gained prescriptions when rofecoxib (Vioxx, Merck) was pulled from the market and again when Pfizer's own ...

In the case of Celebrex, the National Cancer Institute suspended the use of the drug after discovering that patients taking the largest doses 400 to 800 milligrams a day had a 2.5 times greater risk ...

NEW YORK — Pfizer's surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors' concerns over the pharmaceutical ...